Variability of gross tumor volume delineation in head-and-neck cancer using PET/CT fusion, Part II: the impact of a contouring protocol.

The purpose of this study was to assess the efficacy of a gross tumor volume (GTV) contouring protocol on interobserver variability between 4 physicians in positron emission therapy/computed tomography (PET/CT) treatment planning of head-and-neck cancer. A GTV contouring protocol for PET/CT treatment planning was developed utilizing 4 stages: Preliminary contouring on CT alone, determination of appropriate PET windowing, accurate image registration, and modification of CT contouring with correctly formatted PET/CT display and rules for modality disagreement. Two neuroradiologists and 2 radiation oncologists (designated as A, B, C, and D, respectively) were given a tutorial of PET/CT coregistered imaging individualized to their skill level, which included a step-by-step explanation of the protocol with clinical examples. Opportunities for questions and hands-on practice were given. The physicians were asked to re-contour 16 head-and-neck patients from Part I on PET/CT fusion imaging. Differences in volume magnitude were analyzed for statistical significance by analysis of variance (ANOVA) and paired t-tests (alpha<0.05). Volume overlap was analyzed for statistical significance using Wilcoxon signed-rank tests (alpha<0.05). Volume overlap increased significantly from Part I to Part II (p<0.05). One previously significant difference between physicians disappeared with the protocol in place. The mean fusion volume of Physician C, however, remained significantly larger than that of Physician D (p<0.01). This result is unchanged from Part I. The multidisciplinary contouring protocol significantly improved the coincidence of GTVs contoured by multiple physicians. The magnitudes of the volumes showed marginal improvement in consistency. Developing an institutional contouring protocol for PET/CT treatment planning is highly recommended to reduce interobserver variability.

[1]  B J Mijnheer,et al.  Variability in target volume delineation on CT scans of the breast. , 2001, International journal of radiation oncology, biology, physics.

[2]  Bernard Dubray,et al.  Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  Jean-François Daisne,et al.  Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.

[4]  R. Coleman,et al.  Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  E van der Schueren,et al.  Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Peter A S Johnstone,et al.  FDG-PET in radiotherapy treatment planning: Pandora's box? , 2004, International journal of radiation oncology, biology, physics.

[7]  J Aoki,et al.  FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. , 2001, Radiology.

[8]  D. Visvikis,et al.  Impact of combined 18F-FDG PET/CT in head and neck tumours , 2005, British Journal of Cancer.

[9]  Mithat Gonen,et al.  Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.

[10]  Cyrill Burger,et al.  Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. , 2003, International journal of radiation oncology, biology, physics.

[11]  C B Caldwell,et al.  Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. , 2001, International journal of radiation oncology, biology, physics.

[12]  Tohru Shiga,et al.  Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. , 2002, International journal of radiation oncology, biology, physics.

[13]  S Senan,et al.  Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Yoshimi Anzai,et al.  FDG‐PET/CT–guided intensity modulated head and neck radiotherapy: A pilot investigation , 2005, Head & neck.

[15]  Marcel van Herk,et al.  Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Dwight E Heron,et al.  Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report. , 2004, International journal of radiation oncology, biology, physics.

[17]  Thomas Krauss,et al.  Conformal radiotherapy planning of cervix carcinoma: differences in the delineation of the clinical target volume. A comparison between gynaecologic and radiation oncologists. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Neil G Burnet,et al.  Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: quality assurance for the SIOP PNET 4 trial protocol. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  R. Fisher,et al.  Measurement of lung tumor volumes using three-dimensional computer planning software. , 2002, International journal of radiation oncology, biology, physics.

[20]  J P Logue,et al.  Clinical variability of target volume description in conformal radiotherapy planning. , 1998, International journal of radiation oncology, biology, physics.

[21]  Paul Kinahan,et al.  Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.

[22]  Philippe Lambin,et al.  The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. , 2006, Cancer treatment reviews.

[23]  CT in PET/CT: essential features of interpretation. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  A. Riegel,et al.  Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. , 2005, International journal of radiation oncology, biology, physics.

[25]  Dean Billheimer,et al.  Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  D. Jones,et al.  An estimate of the margin required when defining blocks around the prostate. , 1995, The British journal of radiology.

[27]  K. Holli,et al.  Quality assurance in radiotherapy of breast cancer--variability in planning target volume delineation. , 2001, Acta oncologica.

[28]  Xavier Geets,et al.  Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  Arjan Bel,et al.  Definition of gross tumor volume in lung cancer: inter-observer variability. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  C. Rübe,et al.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  H. Yagata,et al.  Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2‐deoxy‐2‐fluoro[18F]‐D‐glucose , 1998, Cancer.

[32]  X Allen Li,et al.  Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[33]  C. Hess,et al.  The Impact of Gross Tumor Volume (GTV) and Clinical Target Volume (CTV) Definition on the Total Accuracy in Radiotherapy , 2003, Strahlentherapie und Onkologie.

[34]  M van Herk,et al.  The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. , 1997, International journal of radiation oncology, biology, physics.

[35]  L. Stitt,et al.  Variability of target volume delineation in cervical esophageal cancer. , 1998, International journal of radiation oncology, biology, physics.

[36]  Marcel van Herk,et al.  Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. , 2006, International Journal of Radiation Oncology, Biology, Physics.